Dr. Reddy's Laboratories Ltd Common Stock (RDY)

Total Current Liabilities

₹157.34B

Quarterly · Period ending: · INR

RDY logo

RDY Total Current Liabilities

Latest reported₹157.34B INR
RDY Quarterly Current Liabilities · INR (₹2.82B → ₹157.34B)
High-resolution chart · PNG

RDY total current liabilities history

Quarterly · INR. Dates are reporting period ends; fiscal years can differ from calendar years.

Dr. Reddy's Laboratories Ltd Common Stock Total Current Liabilities — Quarterly (INR)
Period endingTotal Current Liabilities (INR)
157,341,000,000
164,248,644,000
158,310,000,000
150,927,000,000
142,591,000,000
130,392,000,000
131,950,000,000
129,299,000,000
105,673,000,000
96,039,000,000
1,124,814,108
84,183,000,000
80,767,000,000
85,845,000,000
1,019,980,659
983,770,993
1,149,653,360
1,240,712,636
1,125,355,061
1,157,279,983
1,231,333,243
1,140,565,215
1,011,010,367
1,064,909,189
1,058,013,674
962,495,662
906,355,796
61,176,000,000
60,980,000,000
59,700,000,000
62,560,000,000
71,306,000,000
70,262,000,000
69,692,000,000
73,198,000,000
70,339,000,000
65,520,000,000
85,000,000,000
95,281,000,000
89,487,000,000
67,209,000,000
64,646,000,000
63,271,000,000
65,491,000,000
64,626,000,000
63,995,000,000
58,481,000,000
54,733,000,000
52,943,000,000
54,063,000,000
56,557,000,000
55,013,000,000
59,542,000,000
536,464,000,000
49,744,000,000
47,531,000,000
47,400,000,000
43,460,000,000
51,597,000,000
51,534,000,000
40,888,000,000
41,015,000,000
33,042,000,000
33,010,000,000
29,970,000,000
29,022,000,000
21,923,000,000
24,024,000,000
531,000,000
26,553,000,000
28,323,000,000
28,694,249,000
23,273,367,000
19,392,280,000
17,521,298,314
16,992,899,209
15,138,592,471
18,577,352,221
24,039,971,493
26,915,841,850
24,648,487,358
18,793,290,026
9,399,927,760
9,096,610,743
8,778,304,172
7,581,921,003
5,654,782,495
5,748,990,871
7,077,425,057
4,575,575,054
3,752,465,715
3,833,821,477
3,500,372,250
3,094,502,700
2,719,808,114
2,586,859,970
2,829,814,979
2,358,143,648
2,291,469,827
2,429,847,323
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.